Compare ARK Genomic Revolution ETF (ARKG) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Rivian Automotive, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Rivian Automotive, Inc. trades at $16.94 (market cap $25.30B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Rivian Automotive, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | RIVN | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $22.45 |
52-Week Low | $23.09 | $11.64 |
Market Cap | — | $25.30B |
Enterprise Value | — | $27.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Rivian (RIVN) trades at $17.48, down 3.69% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company continues to post revenue growth, reaching $5.39 billion in 2025, but remains unprofitable with a net loss of $3.65 billion. Recent news highlights a $1.74 billion stock offering for factory expansion, causing dilution concerns but also reflecting growth ambitions.
The outlook hinges on Rivian's ability to scale production and achieve profitability, supported by analyst consensus targets of $20. Key risks include persistent cash burn, competitive pressures, and execution challenges. The stock presents a high-risk, high-reward opportunity for investors betting on the EV maker's long-term growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
